Amalgamated Bank’s CorMedix CRMD Stock Holding History

Amalgamated Bank’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,333	Closed	-$27K	–	1903
2025 Q4	$27K	Buy	2,333 +244	+12%	+$2.7K	﹤0.01%	1998
2025 Q3	$24K	Hold	2,089	–	–	﹤0.01%	2044
2025 Q2	$26K	Hold	2,089	–	–	﹤0.01%	2016
2025 Q1	$13K	Buy	2,089 +160	+8%	+$1.66K	﹤0.01%	2243
2024 Q4	$16K	Hold	1,929	–	–	﹤0.01%	2205
2024 Q3	$16K	Hold	1,929	–	–	﹤0.01%	2217
2024 Q2	$8K	Buy	1,929 +425	+28%	+$2.16K	﹤0.01%	2543
2024 Q1	$6K	Sell	1,504 -4,638	-76%	-$16.1K	﹤0.01%	2633
2023 Q4	$23K	Sell	6,142 -448	-7%	-$1.54K	﹤0.01%	2579
2023 Q3	$24K	Hold	6,590	–	–	﹤0.01%	2557
2023 Q2	$26K	Buy	+6,590	New	+$32.6K	﹤0.01%	2608
2022 Q2	–	Sell	-4,747	Closed	-$26K	–	3065
2022 Q1	$26K	Buy	+4,747	New	+$21.7K	﹤0.01%	2715

Other funds holding CRMD

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Amalgamated Bank's CRMD Position: Q1 2026 in Review

Amalgamated Bank sold out of CorMedix (CRMD) in Q1 2026, closing a stake of 2,333 shares — an estimated $27K sold.

Amalgamated Bank first reported a position in CRMD in Q1 2022 and held it in 12 quarters. The position peaked at $27K in Q4 2025. 188 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

Amalgamated Bank reported no remaining CorMedix position as of Q1 2026 after selling out during the quarter.
Amalgamated Bank sold 2,333 CorMedix shares in Q1 2026, an estimated $27K.
Amalgamated Bank first reported a position in CorMedix in Q1 2022 and held it in 12 quarters.
Amalgamated Bank's CorMedix position peaked at $27K in Q4 2025.
188 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.